Renaissance Capital logo

ALNA News

US IPO Weekly Recap: No Pop! for Funko in 9 IPO week

ALTR

Average first day pops ranged from -41% to +41% as nine deals raised a combined $2.1 billion this week. High-end software provider Altair was the top performer, returning 41% on its market debut, as investors valued its sticky...read more

Funko plummets 41% in biggest IPO drop since 2000

Allena Pharmaceuticals logo

Pop culture figurine maker Funko (FNKO) fell 41% on Thursday to close at $7.07. That gave it the worst first-day return for an IPO in 17 years, since June 2000 financial services IPO eChapman.com (-43%). Funko priced a downsized IPO at $12 per...read more

Kidney disease biotech Allena Pharmaceuticals prices IPO at $14 low end

Allena Pharmaceuticals logo

Allena Pharmaceuticals, which is developing enzymes for rare and severe metabolic and kidney disorders, raised $75 million by offering 5.3 million shares at $14, the low end of the range of $14 to $16. Allena Pharmaceuticals plans to list on the Nasdaq under the...read more

US IPO Week Ahead: Bobbleheads, biotechs, software and more in a 9-IPO week

ALTR

The IPO market's active fourth quarter continues with another busy week. As many as nine IPOs plan to raise $2.1 billion. This week features three growth IPOs, all with positive operating income: toy maker Funko (FNKO), chip producer...read more